Valuation: Cutia Therapeutics

Market Cap 772M 894M 114M 99.93M 92.37M 84.95M 160M 10.99B 163M 1.1B 433M 5.38B 428M 419M 18.53B P/E 2026 *
-4.64x
P/E 2027 * 16.3x
Enterprise Value 841M 973M 124M 109M 101M 92.51M 175M 11.97B 177M 1.2B 471M 5.86B 466M 456M 20.18B EV / Sales 2026 *
1.3x
EV / Sales 2027 * 0.65x
Free-Float
35.23%
Yield 2026 *
-
Yield 2027 * -
1 day+1.23%
1 week-7.17%
Current month-13.07%
1 month-23.12%
3 months-48.21%
6 months-49.49%
Current year-45.81%
1 week 2.37
Extreme 2.37
2.64
1 month 2.37
Extreme 2.37
3.14
Current year 2.37
Extreme 2.37
5.51
1 year 2.37
Extreme 2.37
12
3 years 2.37
Extreme 2.37
31
5 years 2.37
Extreme 2.37
32.6
10 years 2.37
Extreme 2.37
32.6
Manager TitleAgeSince
Chief Executive Officer 48 2019-08-31
Director of Finance/CFO 36 2021-05-09
Chief Tech/Sci/R&D Officer 42 2020-01-09
Director TitleAgeSince
Chairman 63 2019-08-22
Director/Board Member 48 2023-06-11
Director/Board Member 57 2025-12-29
Date Insider Type Main position Quantity % Market Cap.
10/15/24 Other

Founder

15,000 0.0049%
10/3/24 Other

Chief Financial Officer

20,000 0.0066%
10/2/24 Other

Chief Financial Officer

30,000 0.0098%
Change 5-day change 1-year change 3-year change Capi.($)
+1.23%-7.17%-75.45%-88.00% 113M
-2.73%-3.51%+48.62%+152.87% 1,051B
-1.67%-3.18%+52.00%+56.75% 609B
-0.44%+2.14%+33.88%+84.04% 450B
-0.75%-1.46%+28.32%+22.33% 330B
-1.52%-0.95%+33.38%+38.39% 284B
-1.70%-3.54%+20.26%+17.88% 263B
-0.58%+1.78%-20.89%-38.37% 223B
-0.58%+0.21%+23.55%+56.94% 198B
-0.80%+2.60%+23.09%+68.71% 167B
Average -0.75%-0.35%+16.68%+37.15% 357.52B
Weighted average by Cap. -1.16%+0.02%+35.25%+75.57%

Financials

2026 *2027 *
Net sales 646M 748M 95.38M 83.6M 77.27M 71.07M 134M 9.2B 136M 924M 362M 4.5B 358M 350M 15.5B 1.18B 1.37B 174M 153M 141M 130M 245M 16.8B 249M 1.69B 662M 8.22B 654M 640M 28.32B
Net income -146M -169M -21.52M -18.86M -17.44M -16.04M -30.26M -2.08B -30.74M -208M -81.73M -1.02B -80.81M -79.05M -3.5B 44.25M 51.23M 6.53M 5.73M 5.29M 4.87M 9.19M 630M 9.33M 63.3M 24.81M 308M 24.54M 24M 1.06B
Net Debt 68.7M 79.54M 10.15M 8.89M 8.22M 7.56M 14.26M 978M 14.49M 98.28M 38.53M 479M 38.09M 37.26M 1.65B -
Logo Cutia Therapeutics
Cutia Therapeutics is an investment holding company principally engaged in the dermatology biopharmaceutical business. The Company is dedicated to developing solutions in the dermatology treatment and care market, including scalp diseases and care, skin diseases and care, topical anesthesia and localized adipose accumulation management. The Company is primarily engaged in the distribution of scalp diseases and care products, as well as certain skin care products. The Company's principal pipeline products include topical finasteride spray CU-40102, topical 4% minocycline foam CU-10201, topical novel small molecule agent CU-10101, localized topical lidocaine and tetracaine cream CU-30101 and recombinant mutant collagenase CU-20401.
Employees
304
Date Price Change Volume
26-07-20 HK$2.460 +1.23% 1,200
26-07-17 HK$2.430 -5.45% 87,600
26-07-16 HK$2.570 +2.80% 179,400
26-07-15 HK$2.500 -1.57% 147,600
26-07-14 HK$2.540 -0.39% 87,000
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.125CNY
Average target price
9.801CNY
Spread / Average Target
+361.31%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2487 Stock